Found 76 matching trials
A Metal Bare Stent With 125 Iodine (125I)Seeds for the Treatment of Malignant Central Airway Stenosis
NAMalignant central airway stenosis caused by primary or metastatic malignant...
Location
The first affiliated hospital of wenzhou medical university
Ability of a New Design of Iodine 125 Seed to Maintain Intended Position When Implanted in the Prostate
PHASE3This study compares the ability of a new design of brachytherapy seed for p...
Location
Cancer Center for the Southern Interior
Androgen Suppression Combined With Elective Nodal and Dose Escalated Radiation Therapy
PHASE3The purpose of this trial is to compare two similar treatments for patients...
Side Effects of Low Dose Rate Brachytherapy and Ultra-hypofractionated Radiotherapy in Low to Intermediate Risk Prostate Cancer
NAThe LDR BURST trial will compare the side effects of two radiotherapy treat...
Location
Royal Surrey NHS Foundation Trust
Implant Radiation Therapy Using Radioactive Iodine in Treating Patients With Localized Prostate Cancer
N/ARATIONALE: Implant radiation therapy delivers a high dose of radiation dire...
Location
Fujita Health University
Neoadjuvant Carboplatin and Vincristine and Standard Local Ophthalmic Therapy in Treating Patients With Intraocular Retinoblastoma
PHASE3This phase III trial is studying how well giving carboplatin and vincristin...
Location
Children's Hospital Los Angeles
Hormone Therapy Followed By Internal Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer
PHASE2RATIONALE: Androgens can stimulate the growth of prostate cancer cells. Dru...
Location
CCOP - Scottsdale Oncology Program
Luteinizing Hormone-Releasing Hormone Agonist Therapy and Iodine I 125 Implant in Treating Patients With Previously Untreated Prostate Cancer
PHASE3RATIONALE: Androgens can cause the growth of prostate cancer cells. Luteini...
Location
The Jikei University School of Medicine
I-125 Versus Pd-103 for Medium Risk Prostate Cancer
PHASE3hypothesis: the shorter half-life of Pd-103 versus I-125, will increase the...
Location
Group Health Cooperative
A Phase II Study of Adjuvant Use of Anti-Epidermal Growth Factor Receptor EGFR-425 in High Grade Gliomas
PHASE2Data from the wistar institute indicated that this anti-body labeled with i...
Location
Hahneman Hospital